Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Ideaya hires J.P. Morgan veteran Joshua Bleharski as CFO

Plus: Winselow Tucker named president of Lilly India, and updates from Santhera, Aurion and Oncolytics

February 11, 2025 1:36 AM UTC

Oncology company Ideaya Biosciences Inc. (NASDAQ:IDYA) hired Joshua Bleharski as CFO. Bleharski was managing director and global co-head of biopharma of J.P. Morgan’s Healthcare Investment Banking group, where he held roles for nearly 17 years. 

Eli Lilly and Co. (NYSE:LLY) named Winselow Tucker to lead operations in India as president and general manager. Tucker was group VP and chief commercial officer of Lilly Oncology. Lilly added that Vineet Gupta, associate VP, managing director India, will move to a new, U.S.-based role...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article